The hopes and fears of in utero gene therapy for genetic disease - A review

Placenta

Volumn 24, Issue SUPPL. B, 2003, Pages

  Coutelle, C ^a   Themis, M ^a   Waddington, S ^a   Gregory, L ^a   Nivsarkar, M ^a   Buckley, S ^a   Cook, T ^a   Rodeck, C ^b   Peebles, D ^b   David, A ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ACTIN; BLOOD CLOTTING FACTOR 9; CREATINE KINASE; CYTOKERATIN 18; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN INHIBITOR; VIRUS VECTOR;

ANIMAL MODEL; CARCINOGENESIS; CONGENITAL MALFORMATION; DNA VECTOR; DRUG ADMINISTRATION ROUTE; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; GERM LINE; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STEM CELL; TARGET ORGAN; TISSUE INJURY; TRANSGENE;

EID: 10744232558     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00140-1     Document Type: Review

References (33)

1. Bigger BW & Coutelle C (2001) Perspectives on gene therapy for cystic fibrosis airway disease. BioDrugs, 15, 615-634.
2. Brennan KJ & Hardeman EC (1993) Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J Biol Chem, 268, 719-725.
3. Burns J, Friedmann T, Driever W, Burrascano M & Yee J-K (1993) Vesicular stomatitis virus G glycoprotein peudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A, 90, 8033-8037.
4. Colledge W, Alton E, Smith S, Geddes D, Larson JE, Morrow SL & Cohen JC (1997) Correspondence; Gene therapy for cystic fibrosis. Lancet, 349, 1249-1250.
5. Coutelle C, Douar A-M, College WH & Froster U (1995) The challenge of fetal gene therapy. Nature Med, 1, 864-866.
6. Chow YH, O'Brodovich H, Plumb J, Wen Y, Sohn KJ, Lu Z, Zhang F, Lukacs GL, Tanswell AK, Hui CC, Buchwald M & Hu J (1997) Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways. Proc Natl Acad Sci U S A, 94, 14695-14700.
7. David AL, Themis M, Cook T, Coutelle C & Rodeck C (2001) Fetal gene therapy. Ultrasound Rev Obstet Gynecol, 1, 14-27.
8. David A, Cook T, Waddington S, Peebles D, Nivsarkar M, Miah M, Dahse T, Noakes D, Schneider H, Rodeck C, Coutelle C & Themis M (2003a) Ultrasound guided percutaneous delivery of adenoviral vectors encoding the β-galactosidase and human factor IX genes to early gestation fetal sheep in utero. Hum Gene Therapy, 14, 353-364.
9. David AL, Peebles D, Gregory L, Themis M, Cook T, Miah M, Coutelle C, Kiserud T & Rodeck CH (2003b) Ultrasound-guided injection of the trachea in fetal sheep: a novel percutaneous technique to target the fetal airways in utero. Fetal Diagnosis and Therapy (in press).
10. Douar A-M, Themis M, Friedman T & Coutelle C (1996) Effect of amniotic fluid on cationic lipid mediated transfection and viral infection. Gene Therap, 3, 789-796.
11. Douar AM, Adebakin S, Themis M, Pavirani A, Cook T & Coutelle C (1997) Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther, 4, 883-890.
12. Ferrer A, Wells KE & Wells DJ (2000) Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy. Gene Therapy, 7, 1439-1446.
13. Fletcher J & Richter G (1996) Human fetal gene therapy: moral and ethical questions. Hum Gene Ther, 7, 1605-1614.
14. Gregory L, Holder M, Mitrophanous K, Waddington S, Bigger B, Lawrence L Cook T, Allaf F, Kingsman S, Coutelle C & Themis M (2003a) Highly efficient gene transfer and persisent musculature gene expression following in utero application demonstrates applicablity of EIAV lentivirus for gene therapy of Duchenne/Becker Muscular Dystrophies (submitted).
15. Gregory LG, Harbottle RP, Lawrence L, Knapton H, Themis M & Coutelle C (2003b) Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo. Molecular Therapy, 7, 19-26.
16. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 348, 255-256.
17. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV & Chamberlain JS (2002) Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nature Medicine, 8, 253-261.
18. Kazazian H (1999) An estimated frequency of endogenous insertional mutations in humans. Nature Genet, 22, 130.
19. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H, et al. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet, 45, 498-506.
20. Larson J, Morrow SL, Happel L, Sharp JF & Cohen JC (1997) Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet, 349, 619-620.
21. Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DG, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High KA & Glader B (2003) AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood, 101, 2963-2972.
22. Peebles D, Gregory L, David A, Themis M, Knapton H, Miah M, Cook T, Lawrence L, Nivsarkar M, Rodeck C & Coutelle C (2003) Widespread and efficient marker gene expression in the airway epithelia of fetal sheep by ultrasound-guided percutaneous application of recombinant adenovirus in combination with caprate to the trachea in utero (submitted).
23. Porada C, Tran N, Eglitis M, Moen RC, Troutman L, Flake AW, Zhao Y, Anderson WF & Zanjani ED (1998) In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther, 9, 1571-1585.
24. Ragni M (2002) Safe passage: a plea for safety in hemophilia gene therapy. Mol Ther, 6, 436.
25. Schneider H, Adebakin S, Themis M, Cook T, Douar A-M, Pavirani A & Coutelle C (1999) Therapeutic concentrations of human factor IX in mice after gene delivery into the amniotic cavity: A model for the prenatal treatment of haemophilia B. J Gene Med, 1, 424-432.
26. Schneider H, Mühle C, Douar A-M, Waddington S, Jiang Q-J, von der Mark K, Coutelle C & Rascher W (2002) Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administered in utero. J Gene Medicine, 4, 46-53.
27. Snyder R, Miao C, Meuse L, Tubb J, Donahue BA, Lin H-F, Stafford DW & Kay MA (1999) Correction of hemophilia B in canine and murine models using recombinant adeno-associated vectors. Nature Med, 5, 64-70.
28. Surbek DV, Young A, Danzer E, Schoeberlein A, Dudler L & Holzgreve W (2002) Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy. Am J Obstet Gynecol, 187, 960-963.
29. Themis M, Schneider H, Kiserud T, Cook T, Adebakin S, Jezzard S, Hanson M, Pavirani A, Rodeck C & Coutelle C (1999) High level expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided transcutaneous adenovirus vector administration into the umbilical vein. Gene Therapy, 6, 1239-1248.
30. Tizzano EF, O'Brodovich H, Chitayat D, Benichou JC & Buchwald M (1994) Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol, 10, 355-362.
31. Turkel SB, Howell R, Iseri AL & Chui L (1981) Ultrastructure of muscle in fetal Duchenne's dystrophy. Arch Pathol Lab Med, 105, 414-418.
32. Waddington S, Buckley S, Nivsarkar M, jezzard S, Schneider H, Tucker N, Dallman M, Themis M & Coutelle C (2003a) In utero gene transfer of human factor IX to fetal mice induces tolerance against the postnatally expressed human protein. Blood, 101, 1359-1366.
33. Waddington S, Nivsarka M, Buckley S, Lawrence L, Cook T, Allaf F, Coutelle C & Themis M (2003b) Long-term postnatal β-galactodsidase expression in transduced hepatocytes of immuno-competent mice after in utero delivery of an EAIV derived lentiviral vector via the yolk sac vessels. Gene Therapy (in press).